Blumberg identifies & characterises Hepatitis B virus (HBV) (pictured).
Micro-leukoagglutination test subsequently used for detection of clinically significant granulocyte antibodies, 1st described by van Rood et al in Amsterdam.
The Australian & New Zealand Society of Blood Transfusion (ANZSBT) aims to engage with stakeholders in all areas of transfusion through communication, representation and advocacy.
Get Involved
Explore
Suggest an Edit
The History Committee has made every effort to source & record accurate facts, dates & figures.
Source materials, especially older texts, have been of variable integrity & we welcome notification of any corrections which will improve the accuracy of our historical story.
